Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis
about
Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of miceMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaDiscrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCRTaxonomy and identification of the Burkholderia cepacia complexClinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis.Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosisIn vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepaciaA Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotypingLaboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmissionComparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosisDevelopment of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia.Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaire.Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosisStructurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia.Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.Microbiological processing of respiratory specimens from patients with cystic fibrosis.Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.Plasmids of Pseudomonas cepacia strains of diverse origins
P2860
Q27302803-761F55F3-776E-41C4-A329-A65FEBE46B07Q29615286-43739FE9-5E48-4A60-919B-78FF0C16C89AQ33960094-C4279F01-DC1A-4AB8-9E86-508F0D4E6CECQ33973532-69CCFA36-AA47-44CC-A678-D44EAB74F6D7Q34041641-46BD43D6-08A4-491C-87B5-BBC52771F286Q34568983-C192F322-BD53-4ECB-8C28-8ECEA1AFE095Q35807882-B1423D85-70DF-4A04-8DC3-E40C7E498806Q36834752-C983B4F7-039E-4DDA-9BA2-2C945711026AQ37040505-8FEC7ED2-98DF-481A-B14A-BD1BBED7548CQ37092347-C4E3ACD6-4185-4069-84AA-26A8CE6477D5Q37125372-3C174E11-EA51-4FE4-909E-CD40D50E85F2Q37137659-10B67134-7F85-497A-9C07-AFF468DA252FQ37142382-F664CBF8-2355-48D1-BC93-55DDD4EE0700Q37156638-96217BE9-9B5F-4E35-AF90-14383227A930Q37168589-D9EEB86D-A19F-4195-934B-0903AF526DCEQ37215494-26EC3D77-7372-4865-AE97-311D93078867Q37248139-B80D189E-D264-446C-9C31-C27E66CBFDD6Q38323549-4D686168-4768-4127-9A9E-84CCC160A966Q39467759-283E19C3-CAC6-4658-8667-BF3EAB54EB41Q39648598-53B39174-5DB2-443F-B18F-E5989772227DQ39835718-5AED1360-3DE8-4695-834A-735BDCBE2E4DQ40010382-28242509-2D43-486E-9733-18176706FC5AQ40013162-9CF63839-9FB3-41D2-8DDF-65D72033D255Q40141799-25122C92-9CB2-45F7-8A79-217AD6537E1AQ40208881-C9F08E2E-D417-4FCC-AA26-A4C0FE8C89BBQ40214870-4A4B9CDA-F3BA-49C3-A644-6B705A609277Q41866915-3E7CAF4C-E728-40CF-AC19-E7464C1B2766
P2860
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isolation medium for the recov ...... patients with cystic fibrosis
@en
Isolation medium for the recov ...... patients with cystic fibrosis.
@nl
type
label
Isolation medium for the recov ...... patients with cystic fibrosis
@en
Isolation medium for the recov ...... patients with cystic fibrosis.
@nl
prefLabel
Isolation medium for the recov ...... patients with cystic fibrosis
@en
Isolation medium for the recov ...... patients with cystic fibrosis.
@nl
P2093
P2860
P1476
Isolation medium for the recov ...... patients with cystic fibrosis
@en
P2093
Bradshaw LM
DeCicco BT
Gilligan PH
Schidlow DV
P2860
P407
P577
1985-07-01T00:00:00Z